Przydatność oznaczania KIM-1 w moczu dzieci z idiopatycznym zespołem nerczycowym leczonych cyklosporyną A

• Authors: Jakubowska Anna , Zwolinska Danuta , Kiliś - Pstrusińska Katarzyna
• Languages of publication: PL

Keywords

PL

dzieci; cyklosporyna A; idiopatyczny zespół nerczycowy; KI M-1

• Publisher: Stowarzyszenie Przyjaciół Medycyny Rodzinnej i Lekarzy Rodzinnych
• Journal: Family Medicine & Primary Care Review
• Year: 2016
• Issue: 2
• Pages: 103-108

Contributors

author

Jakubowska Anna

author

Zwolinska Danuta

author

Kiliś - Pstrusińska Katarzyna

References

• Kim JS, Bellew CA, Silverstein DM, et al. High incidence of initial and late steroid resistance in childhood nephrotic syndrome.Kidney Int 2005; 68(3): 1275–1281.
• Zagury A, Oliveira AL , Montalvão JA, et al. Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease. J Bras Nefrol 2013; 35(3): 191–199.
• Ishikura K, Ikeda M, Hattori S, et al. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int 2008; 73(10): 1167–1173.
• Huo W, Zhang KE, Nie Z, et al. Kidney injury molecule-1 (KI M-1): a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev 2010; 24(3): 143–146.
• Marchewka Z, Płonka J. The diagnostic importance of the new marker KI M-1 in kidney damage. Post Hig Med Dosw (online)2013; 67: 695–699.
• Han WK , Bailly V, Abichandani R. Kidney Injury Molecule-1 (KI M-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62(1): 237–244.
• International Study of Kidney Disease in Children. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A R eport of the International Study of Kidney Disease in Children. Kidney Int 1981; 20(6): 765–771.
• KDIGO Clinical Practice Guideline for Glomerulonephritis Kidney Int Suppl. 2012; 2(2): 139–274.
• Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants,children, and adolescents. Pediatr Clin North Am 1987; 34(3): 571–590.
• Pulin AA , Brovko M, Kustova T, et al. Clinical significance of serum and urinary biomarkers for water-salt metabolism in patients with proteinuric forms of chronic glomerulonephritis Ter Arkh 2014; 86(6): 24–29.
• Vaidya VS, Ford GM, Waikar SS , et al. A rapid urine test for early detection of kidney injury. Kidney Int 2009; 76(1): 108–114.
• Carlos CP, Sonehara NM, Oliani SM, et al. Predictive usefulness of urinary biomarkers for the identification of cyclosporine Ainduced nephrotoxicity in a rat model. PLoS ONE 2014; 9(7): e103660.
• Lim AI , Tang SC, Lai KN , et al. Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? J Cell Physiol 2013; 228(5): 917–924.
• van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KI M-1) in human renal disease.J Pathol 2007; 212(2): 209–217.
• Alter ML, Kretschmer A, Von Websky K, et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab 2012; 58(7–8): 659–671.
• Nauta FL, Boertien WE, Bakker SJ, et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 2011; 34(4): 975–981.
• Wahlstedt-Fröberg V, Pettersson T, Aminoff M, et al. Proteinuria in cubilin-deficient patients with selective vitamin B12 malabsorption.Pediatr Nephrol 2003; 18(5): 417–421.
• D’Amico G, Bazzi C. Pathophysiology of proteinuria. Kidney Int 2003; 63(3): 809–825.
• Bennett MR, Nehus E, Haffner C, et al. Pediatric reference ranges for acute kidney injury biomarkers. Pediatr Nephrol 2015;30(4): 677–685.
• Wasilewska A, Taranta-Janusz K, Dębek W, et al. KI M-1 and NGAL : new markers of obstructive nephropathy. Pediatr Nephrol 2011; 26(4): 579–586
• Du Y, Hou L, Guo J, et al. Renal neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 expression in children with acute kidney injury and Henoch-Schönlein purpura nephritis. Exp Ther Med 2014; 7(5): 1130–1134